These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15378599)

  • 21. Paclitaxel-induced immune suppression is associated with NF-kappaB activation via conventional PKC isotypes in lipopolysaccharide-stimulated 70Z/3 pre-B lymphocyte tumor cells.
    Lee M; Jeon YJ
    Mol Pharmacol; 2001 Feb; 59(2):248-53. PubMed ID: 11160860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of SRC tyrosine kinase impairs inherent and acquired gemcitabine resistance in human pancreatic adenocarcinoma cells.
    Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
    Clin Cancer Res; 2004 Apr; 10(7):2307-18. PubMed ID: 15073106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of autophagy sensitizes multidrug resistant cells towards Src tyrosine kinase specific inhibitor PP2.
    Ahn JH; Lee M
    Cancer Lett; 2011 Nov; 310(2):188-97. PubMed ID: 21775053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pervanadate-induced reverse translocation and tyrosine phosphorylation of phorbol ester-stimulated protein kinase C betaII are mediated by Src-family tyrosine kinases in porcine neutrophils.
    Takahashi H; Suzuki K; Namiki H
    Biochem Biophys Res Commun; 2004 Feb; 314(3):830-7. PubMed ID: 14741711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Knockout of ATG5 leads to malignant cell transformation and resistance to Src family kinase inhibitor PP2.
    Hwang SH; Han BI; Lee M
    J Cell Physiol; 2018 Jan; 233(1):506-515. PubMed ID: 28294316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Src kinase activity is required for integrin alphaVbeta3-mediated activation of nuclear factor-kappaB.
    Courter DL; Lomas L; Scatena M; Giachelli CM
    J Biol Chem; 2005 Apr; 280(13):12145-51. PubMed ID: 15695822
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells.
    Spreafico A; Schenone S; Serchi T; Orlandini M; Angelucci A; Magrini D; Bernardini G; Collodel G; Di Stefano A; Tintori C; Bologna M; Manetti F; Botta M; Santucci A
    FASEB J; 2008 May; 22(5):1560-71. PubMed ID: 18171692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Src tyrosine kinase inhibitor PP2 markedly enhances Ras-independent activation of Raf-1 protein kinase by phorbol myristate acetate and H2O2.
    Lee M; Kim JY; Anderson WB
    J Biol Chem; 2004 Nov; 279(47):48692-701. PubMed ID: 15356004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Src-dependent aprotein kinase C iota/lambda (aPKCiota/lambda) tyrosine phosphorylation is required for aPKCiota/lambda association with Rab2 and glyceraldehyde-3-phosphate dehydrogenase on pre-golgi intermediates.
    Tisdale EJ; Artalejo CR
    J Biol Chem; 2006 Mar; 281(13):8436-42. PubMed ID: 16452474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin beta3-mediated Src activation regulates apoptosis in IEC-6 cells via Akt and STAT3.
    Bhattacharya S; Ray RM; Johnson LR
    Biochem J; 2006 Aug; 397(3):437-47. PubMed ID: 16669788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173.
    Kong L; Deng Z; Shen H; Zhang Y
    Mol Cell Biochem; 2011 Feb; 348(1-2):11-9. PubMed ID: 21052789
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent manner.
    Hishiki T; Saito T; Sato Y; Mitsunaga T; Terui E; Matsuura G; Saito E; Shibata R; Mise N; Yokoyama Y; Yoshida H
    Pediatr Surg Int; 2011 Feb; 27(2):225-30. PubMed ID: 21046121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2).
    Frauenstein K; Tigges J; Soshilov AA; Kado S; Raab N; Fritsche E; Haendeler J; Denison MS; Vogel CF; Haarmann-Stemmann T
    Arch Toxicol; 2015 Aug; 89(8):1329-36. PubMed ID: 25082669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phosphorylation of caveolin-1 on tyrosine-14 induced by ROS enhances palmitate-induced death of beta-pancreatic cells.
    Wehinger S; Ortiz R; Díaz MI; Aguirre A; Valenzuela M; Llanos P; Mc Master C; Leyton L; Quest AF
    Biochim Biophys Acta; 2015 May; 1852(5):693-708. PubMed ID: 25572853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis induced by SRC-family tyrosine kinase inhibitors in cultured rat cortical cells.
    Takadera T; Fujibayashi M; Koriyama Y; Kato S
    Neurotox Res; 2012 Apr; 21(3):309-16. PubMed ID: 22006118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Src kinase mediates the regulation of phospholipase C-gamma activity by glycosphingolipids.
    Shu L; Shayman JA
    J Biol Chem; 2003 Aug; 278(33):31419-25. PubMed ID: 12771140
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GluA2 trafficking is involved in apoptosis of retinal ganglion cells induced by activation of EphB/EphrinB reverse signaling in a rat chronic ocular hypertension model.
    Dong LD; Gao F; Wang XH; Miao Y; Wang SY; Wu Y; Li F; Wu J; Cheng XL; Sun XH; Yang XL; Wang Z
    J Neurosci; 2015 Apr; 35(13):5409-21. PubMed ID: 25834064
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SRC kinase family inhibitor PP2 promotes DMSO-induced cardiac differentiation of P19 cells and inhibits proliferation.
    Gong J; Gu HY; Wang X; Liang Y; Sun T; Liu PJ; Wang Y; Yan JC; Jiao ZJ
    Int J Cardiol; 2013 Aug; 167(4):1400-5. PubMed ID: 22575628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.
    Ceccherini E; Indovina P; Zamperini C; Dreassi E; Casini N; Cutaia O; Forte IM; Pentimalli F; Esposito L; Polito MS; Schenone S; Botta M; Giordano A
    J Cell Biochem; 2015 May; 116(5):856-63. PubMed ID: 25521525
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition.
    Cozzi M; Giorgi F; Marcelli E; Pentimalli F; Forte IM; Schenone S; D'Urso V; De Falco G; Botta M; Giordano A; Indovina P
    Cell Cycle; 2012 Mar; 11(5):1029-39. PubMed ID: 22333592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.